News and commentary from the endocrinology world ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

Please provide your email address to receive an email when new articles are posted on . National and international endocrine, nephrology and pediatric societies are proposing a name change for ...

A study of 98,000 veterans shows that combining GLP-1 RA therapy with healthy lifestyle habits significantly lowers MACE risk in T2D.

November is National Diabetes Month, Hamilton Medical Center and Hamilton Diabetes and Endocrinology Center is promoting awareness of the disease within the area. Diabetes affects about 37 million ...

The US Food and Drug Administration has approved insulin icodec (Awiqli), developed by Novo Nordisk, as the first once-weekly long-acting basal insulin for glycemic control in adults with Type ...

· Metformin should be the initial oral medication used for glycemic management, in addition to lifestyle interventions. · For patients who have not achieved glycemic targets with metformin and ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — When Mihail Zilbermint, MD, MBA, was accepted to music school to become a classical singer, his mentor ...

Our focus is to help our pediatric endocrine fellows become the leaders of tomorrow in pediatric endocrinology and diabetes through an innovative and learner-centered environment committed to ...